Low SIAH2 expression in breast cancer is associated with resistance to endocrine therapy

被引：0
|
作者：
Jansen, M. P. H. M. [1 ]
Dorssers, L. C. J. [1 ]
Ritstier, K. [1 ]
Foekens, J. A. [1 ]
van Staveren, I. L. [1 ]
Helleman, J. [1 ]
Look, M. P. [1 ]
Sieuwerts, A. M. [1 ]
Klijn, J. G. M. [1 ]
Berns, R. M. J. J. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70764-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [31] "Braking" the Cycle of Resistance in Endocrine Therapy for Breast Cancer
    DeMichele, Angela
    Chodosh, Lewis A.
    CLINICAL CANCER RESEARCH, 2015, 21 (22) : 4999 - 5001
  • [32] Predicting response/resistance to endocrine therapy for breast cancer
    WR Miller
    TJ Anderson
    D Evans
    A Krause
    JM Dixon
    Breast Cancer Research, 7
  • [33] Dysregulated TCA cycle is associated with endocrine therapy resistance in ER plus breast cancer
    Sengupta, Surojeet
    de Oliviera, Karla Andrade
    Jin, Lu
    Clarke, Robert
    CANCER RESEARCH, 2022, 82 (12)
  • [34] Inhibition studies of Siah2, a ubiquitin ligase, involved in hypoxia induced cancer
    Gopalsamy, Anupriya
    CANCER RESEARCH, 2011, 71
  • [35] Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer
    Maryam Soleimani Dodaran
    Simone Borgoni
    Emre Sofyalı
    Pernette J. Verschure
    Stefan Wiemann
    Perry D. Moerland
    Antoine H. C. van Kampen
    BMC Cancer, 20
  • [36] Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2-breast cancer
    Dodaran, Maryam Soleimani
    Borgoni, Simone
    Sofyali, Emre
    Verschure, Pernette J.
    Wiemann, Stefan
    Moerland, Perry D.
    van Kampen, Antoine H. C.
    BMC CANCER, 2020, 20 (01)
  • [37] A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese
    Elgazzar, Seham
    Zembutsu, Hitoshi
    Takahashi, Atsushi
    Kubo, Michiaki
    Aki, Fuminori
    Hirata, Koichi
    Takatsuka, Yuichi
    Okazaki, Minoru
    Ohsumi, Shozo
    Yamakawa, Takashi
    Sasa, Mitsunori
    Katagiri, Toyomasa
    Miki, Yoshio
    Nakamura, Yusuke
    JOURNAL OF HUMAN GENETICS, 2012, 57 (12) : 766 - 771
  • [38] Expression of Phosphorylated Activating Transcription factor 2 (ATF2) is associated with sensitivity to endocrine therapy in breast cancer
    Palmieri, C.
    Rudraraju, B.
    Abdel-Fatah, T. M. A.
    Moore, D. A.
    Shaw, J.
    Green, A.
    Ellis, O. I.
    Coombes, R. C.
    Simak, A.
    CANCER RESEARCH, 2012, 72
  • [39] YTHDF1 enhances stemness and chemoresistance in triple-negative breast cancer cells by upregulating SIAH2
    Wu, Anhao
    Wang, Xi
    Zhang, Fang
    Yang, Xin
    Quan, Yuhang
    Dong, Junyu
    Lai, Yafang
    Yang, Dechun
    Sun, Jian
    Wang, Maohua
    MOLECULAR CARCINOGENESIS, 2024, 63 (03) : 417 - 429
  • [40] Cognitive changes associated with endocrine therapy for breast cancer
    Agrawal, Kunal
    Onami, Susan
    Mortimer, Joanne E.
    Pal, Sumanta Kumar
    MATURITAS, 2010, 67 (03) : 209 - 214
12345